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Abstract We have investigated the binding of PI, PIP and PIP2 
to talin and the effect of phosphoinositides and adenosinenucleo- 
tides on talin-induced actin polymerization. At physiological salt 
concentrations, tahn coprecipitates with liposomes when contain- 
ing phosphoinositides but not when containing PI. The nucleating 
effect of talin as reflected by a twofold increase of fluorescence 
during the polymerization of actin labelled with NBD is not 
inhibited by phosphoinositides. The polymerization of ADP-actin 
versus ATP-actin was investigated in the presence and absence of 
talin by NBD fluorescence. ADP-actin nucleation induced by 
talin is comparably effkient as with ATP-actin. These experi- 
mental thuiings in summary have implications when evaluating 
the role of talon during cell activation. 
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1. Introduction 
Investigations over the past few years have lent support to 
the idea that talin serves as a key protein for cytoskeletonl 
membrane interactions (for review see [l]). Evidence for this 
hypothesis comes from the findings that (1) talin binds actin 
[2,3], (2) talin binds to negatively charged phospholipids [4-61, 
(3) talin can be reconstituted into lipid mono- and bilayers 
[7,3] and (4) talin in its membrane bound state is able to 
promote actin filament assembly at the lipid interface 
[8,9,11]. Structural studies have revealed that all these func- 
tions are based on talin operating as a homodimer, a dumb- 
bell-shaped elongated molecule of 51 nm in length with three 
characteristic areas of condensed mass [lo]. Fluorescence as- 
says with NBD-labelled actin polymerized in the presence of 
talin do not show any lag-phase but instead exhibit a rapid 
increase of fluorescence reflecting an increased amount of F- 
actin in comparison with controls. Conversely, when viewed 
by electron microscopy, the early polymerization time course 
(55 min) is characterized by the existence of only short actin 
filaments (51 pm) in length. Hence, it is deduced, that talin 
increases actin filament number concentration over filament 
length. 
Recent reports point to the importance of the balance be- 
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Abbreviations: PC, phosphatidylcholine; PS, phosphatidylserine; 
PIPa, phosphatidyl-inositol-4,5_diphosphate; PIP, phosphatidylinosi- 
tol&monoohosnhate: PI. phosohatidvlinositol: NBD-actin, 7-chloro- 
4-nitro-benzeno:2-oxa-1,3&&e a&n; ADP-actin, adenosine 5’- 
diphosphate; ATP-actin, adenosine 5’-triphosphate 
tween ADP-actin and ATP-actin in cells, especially when actin 
monomer sequestering proteins such as profilin and thymosin 
p4 are present [12]. Some proteins, such as profilin, will accel- 
erate nucleotide exchange on actin [12,13], while others, such 
as cofilin and thymosin p4, inhibit this exchange. Gelsolin on 
the other hand reacts much faster with ADP-actin than with 
ATP-actin [14]. Based on the actual intracellular concentra- 
tions of various binding partners it is possible that the cellular 
source for actin filament elongation is ADP-actin rather than 
ATP-actin [12]. 
Against this background it seemed to us of interest to in- 
vestigate the nucleating effect of talin using ADP-actin versus 
ATP-actin as nucleation source. 
Since the signaling cascade during cell activation gives rise 
to elevated levels of phosphoinositolphosphatides near the 
plasma membrane and these may either inhibit or accelerate 
various actin binding proteins [15], we also tested binding and 
the effect of inositolphosphates on talin promoted actin fila- 
ment polymerization. 
2. Materials and methods 
2.1. Proteins 
Talin was purified from human platelets as described [8]. ATP-actin 
was extracted from skeletal muscle acetone powder [16] and further 
purified by gel filtration [17]. ADP-actin was obtained by passing 
conventional actin over a Sephadex G-25 SF (Pharmacia) gel filtration 
column (2.5X70 cm), equilibrated and eluted with ADP-buffer: 0.5 
mM ADP, 0.01 mM MgCls, 3 mM NaNs, 5 mM triethanolamine/HCl 
pH 7.5. 5 ml actin containing 5% NBD-actin was applied to the 
column and eluted with a flow rate of 20 ml/h. A complete exchange 
of nucleotides was checked by HPLC analysis. ADP-actin was imme- 
diately used for experiments, since it degrades rapidly. 
Protein concentrations were determined according to Bradford [18] 
and the purity was analyzed on SDS-polyacrylamide gels [19]. Con- 
centrations of ATP-actin and ADP-actin were determined photome- 
trically at 290 nm using an absorption coefficient of 24 900 Mm1 cm-‘. 
2.2. Fluorescence 
Actin polymerization was followed by a 2.2-2.5-fold greater fluo- 
rescence intensity of polymeric actin compared to that of monomeric 
actin [20]. 5% of fluorescently labeled actin was copolymerized with 
unmodified actin. This low proportion of labeled actin does not sig- 
nificantly alter the polymerization rate or extent of assembly of un- 
modified actin [21]. The excitation wavelength was 480 nm, and the 
fluorescence intensity was measured at 540 nm. The fluorescence in- 
tensity of monomeric and polymeric actin was calibrated by measur- 
ing the fluorescence intensities of monomeric and polymeric actin to 
evaluate the changes of fluorescence intensities in terms of concentra- 
tions of monomeric and polymeric actin. 
2.3. Sedimentation assays with phosphoinositol containing liposomes 
PC and PS were obtained from Lipid Products, South Nutfield, 
Surrey, England. PIPa, PIP and PI were obtained from Sigma Chem- 
icals. In some of the experiments, PIP2 obtained from Fluka, Switzer- 
0014-5793/96/$12.00 0 1996 Federation of European Biochemical Societies. All rights reserved. 
PIISOOl4-5793(96)01203-3 
G. Isenherg et al.IFEBS Letters 397 (1996) 316-320 317 
200 Kd - 
‘“i 
116 Kd - 
97Kd- \I 
66Kd - or 
45Kd- r, 
34 40 50 60 
Fig. 1. Purity of talin preparations. SDS-polyacrylamide gel showing peak fractions of purified human platelet talin with 95-98% purity. 5 pg 
of protein was applied to each lane. Talin runs at approx. 230 kDa as judged by molecular masses of standard proteins (left lane). 
land, was used. Large, multilamellar liposomes were prepared from 
PC, PS, and PI as described [1 11. Briefly, lipids in chloroform/metha- 
nol were dried under Ns. PIP2 or PIP was added as a stock solution in 
20 mM HEPES pH 7.4, 0.2 mM EGTA to the dried lipids. Lipid 
mixtures were swollen in this buffer for 3 h at 42°C [22]. Vesicles 
were then centrifuged at 200OO~g for 20 min at 4”C, and the pellets 
were resuspended in the same buffer at 5 mg/ml. Talin (dialyzed 
against 20 mM Tris-HCl, pH 7.4, 0.1 mM EDTA, 15 mM mercap- 
toethanol) was centrifuged prior to the experiments for 20 min at 
20 000 X g, followed by protein determination [ 181. Talin (0.1 mg/ml, 
final concentration) was subsequently incubated for 15 min at 22°C in 
the absence of liposomes, followed by a further incubation in the 
absence or presence of liposomes (1.25 mg total lipid/ml, final con- 
centration) for 15 min. In some of the experiments, 130 mM KC1 was 
included in the buffer. The samples were kept under nitrogen during 
incubation with lipids. The mixtures were subsequently centrifuged for 
20 min at 20000 Xg, 4°C. The pellets were solubilized in 50-100 pl 
sample buffer [l 11. The supernatants were mixed with the correspond- 
ing amount of the threefold concentrated sample buffer. After heating 
the samples for 5-10 min at 95”C, they were applied to 5-10% SDS- 
polyacrylamide gradient minigels [19]. The amount of protein present 
in pellets and supernatants was quantified by scanning the bands of 
the Coomassie blue stained gels. The amount of talin sedimented in 
the absence of liposomes was always subtracted from that sedimenting 
in the presence of lipid. The data are given as mean? S.D. of n 
experiments. Differences between data were analyzed with the Stu- 
dent’s t-test for paired data, with a P value of < 0.05 considered 
significant. 
Preparation of phosphoinositol containing solutions for fluores- 
cence assays was performed in talin buffer: 50 mM Tris-HCl pH 
8.0; 3 mM EDTA, 0.1 mM DTT without sonication. 
3. Results 
3.1. Binding of talk to phosphoinositol containing liposomes 
Talin is purified from human platelets with 95-98% purity 
as estimated by SDS-gel electrophoresis (Fig. 1). We have 
previously shown that this fraction of purified talin consists 
of a homogeneous population of molecules as judged by elec- 
tron microscopy representing homodimeric talin in the native 
state [lo]. We have now assayed the capacity of talin to inter- 
act with various phosphoinositol lipids (PI, PIP and PIP$ in 
the absence of salt and by increasing the ionic strength up to 
130 mM KC1 (Fig. 2). In control experiments, talin, at low 
ionic strength, cosediments with mixed PS/PC liposomes, only 
when the PS concentration is higher than 50%. In contrast, 
talin cosedimented significantly (P < 0.0125) with PC lipo- 
somes containing 20% PIP2 or 20% PIP in the presence of 
130 mM KCl, but not at low ionic strength (Fig. 2). Talin 
showed selectivity for PIP2 and PIP, as it did not significantly 
cosediment with liposomes containing 20% PI. 
Cosedimentation with PC liposomes containing 20% PIP:! 
or PIP was also markedly increased when compared to co- 
sedimentation with liposomes containing 20% PS. 
A control protein, bovine serum albumin (BSA), under 
identical conditions did not significantly cosediment with PS 
or PIP2 containing liposomes: 5% of total BSA sedimented in 
1 I 
60 
t T cl - KCI 
50 •I + 130 mM KCI Z = 
aI 
n 4o T 
.E 
g 
30 
!! 
20 
bQ 
10 
0 
50% 
PS 
20% 
PS 
20% 
Plp2 
20% 20% 
PIP PI 
Fig. 2. Cosedimentation of talin with large liposomes containing dif- 
ferent types of phospholipids. Talin (0.1 mg/ml) was incubated for 
15 min at 22°C in the absence or presence of 130 mM KCl, and in 
the presence of large liposomes containing 50% PS, or 80% PC and 
20% PS, or 20% PIP2, 20% PIP, 20% PI, as indicated. After centri- 
fugation at 2OOOOXg, pellets and supernatants were analyzed by 
separation on 5-10% gradient gels and scanning of the Coomassie 
blue stained bands (mean f S.D., n = 34). 
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Fig. 3. Influence of PIP2 on talin nucleated actin polymerization. A: Fluorescence traces of polymerizing NBD-labeled actin (total concentra- 
tion 3 pM) in the absence (lower trace) and presence of 1.5 pM talin (upper trace). The actin concentration (95% actin plus 5% NBD-actin) 
was kept constant in a total volume of 0.75 ml. Polymerization was started by adding polymerization buffer: 2 mM Tris-HC1 pH 8.0, 0.2 mM 
MgCl2, 100 mM KCI, 0.2 mM CaCls, 0.2 mM ATP, 0.2 mM DTT, 0.005% NaN:s. B : Conditions as in A, but with the addition of PIPz. Talin 
was preincubated with 45 pM PIP2 micelles (molar ratio PIPsltalin: 30/l) for 30 min at 20°C (upper trace). As a control, actin alone was poly- 
merized in the presence of 45 pM PIP2 (lower trace). 
the presence of PS liposomes as compared to 2% in its ab- 
sence. 
3.2. Influence of phosphoinositols on talin nucleated actin 
polymerization 
The fluorescence increase of polymerizing actin containing 
5% NBD-actin (total concentration 3 uM) was monitored in 
the presence (1.5 uM) and absence of talin and after the ad- 
dition of various concentrations of phosphoinositols. In con- 
trol samples (Fig. 3A), the addition of talin resulted in the 
previously reported increase in fluorescence during the early 
time course of polymerization. Polymerization of actin started 
immediately without an apparent lag-phase with an approxi- 
mately twofold increase in fluorescence, which reflected the 
rapid formation of polymerization competent nuclei transi- 
ently stabilized by talin. 
In Fig. 3B talin was preincubated with PIPs at a molar 
concentration PIPJtalin of 3O:l for 30 min at 20°C. As 
with PI and PIP at various concentrations (data not shown) 
the incubation with PIP2 did not have any detectable influence 
on talin promoted actin filament nucleation, since the fluo- 
rescent increase was comparable to controls without any 
added phosphoinositols. 
3.3. Talin nucleation of ADP-actin versus ATP-actin 
ADP-actin also polymerizes into filaments, but the critical 
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Fig. 4. Talin nucleated actin polymerization using ADP-actin versus 
ATP-actin as monomers. Fluorescence traces of NBD-labeled (5%) 
ADP-G-actin (total concentration 3 PM) polymerized in polymeriza- 
tion buffer: 2 mM Tris-HCl, pH 7.8, 100 mM KCl, 5 mM MgClz, 
0.5 mM CaCls, 3 mM EDTA, 0.2 mM DTT in the absence (lower 
trace) and presence of 1.4 pM talin (upper trace). Under identical 
conditions ATP-G-actin is polymerized in the absence and presence 
of talin (inset). 
concentration is 55lo-fold higher when compared with ATP- 
actin [23]. In addition, ADP-actin forms polymerization com- 
petent actin nuclei over a much extended time scale ([24], cf. 
Fig. 4) and monomers associated ‘with a filament end 4-5-fold 
slower than ATP-actin subunits [25]. 
Fig. 4 shows the polymerization of ADP-actin with and 
without added talin. Controls exhibit the classical sigmoidal 
shape reflecting (i) an extended nucleation phase as the rate 
limiting reaction during the onset of filament formation, (ii) 
filament elongation and (iii) steady state in the plateau regime. 
In the presence of talin, an always hyperbolic shape is mon- 
itored. The fluorescence without any apparent lag-phase is 
increased by a factor of 22 as deduced from t1j2 and the 
nucleation phase is decreased markedly. 
In effectiveness, the talin enhanced filament formation of 
ADP-actin subunits is comparable with that of ATP-actin 
(Fig. 4, inset). Though, as expected, the time scales differ, 
due to the above mentioned kinetic differences, we measured 
a comparable increase of fluorescence induced by talin for 
both conditions, independent of whether ADP-actin or 
ATP-actin is used. Hence, it is suggested that talin promoted 
filament nucleation occurs independent of the available nu- 
cleotide source on actin subunits. 
4. Discussion 
4.1. The effect ofphosphoinositolphosphatides 
A transient increase of phosphorylated phosphoinositol lip- 
ids is a potential signal for regulating the cytoskeleton during 
cell activation [15,26]. As a consequence, actin binding pro- 
teins that inhibit polymerization, e.g. capping proteins [27], 
may be deactivated by PIP2 [28,29]. On the other hand, 
PIP2 enhanced binding of crosslinking proteins to actin, 
such as a-actinin, may stabilize the newly formed filament 
network [30]. The effect of phosphoinositolphosphates on ta- 
lin, which is thought to be important in targeting and promot- 
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ing actin filament assembly at the lipid interface, therefore 
seemed of special interest to us. 
The cosedimentation assays have shown that talin binding 
to PIP2 and PIP containing liposomes, but not PI containing 
liposomes, is markedly increased under physiological salt con- 
ditions. Interestingly, the talin related protein ezrin, which 
shares about 40% sequence homology in its N-terminal head 
domain with talin [31], has recently been demonstrated to 
interact selectively with PIP2 containing liposomes via this 
N-terminal domain [32]. Hence, homologous lipid interacting 
domains may be involved. However, talin and ezrin also show 
some differences in phosphoinositol interaction: talin, but not 
ezrin, binding to both PIP2 and PIP is elevated under physio- 
logical salt concentrations. On the other hand, ezrin, but not 
talin, is able to discriminate between PIP2 and PIP as a sub- 
strate. Hence, there exists specificity. For both proteins, inter- 
action with PIP2 occurs under physiological ionic conditions, 
but in the absence of salt, talin, unlike ezrin, does not bind 
significantly to any of the phosphoinositol containing lipo- 
somes. 
The elevated concentrations of PIP2 near the plasma mem- 
brane during receptor mediated cell activation [26] may there- 
fore be important to anchor talin in the lipid bilayer. 
As expected from the various functions which have been 
attributed to different domains of the talin molecule [ll], 
PIP2 interaction within the 47 kDa N-terminal head domain 
of talin should not interfere with the nucleation promoting 
activity of talin, which resides in the very C-terminal end 
along the talin sequence. This seems to be the case, since 
under no conditions tested were phosphoinositolphosphates 
of any influence on talin nucleated actin polymerization 
(Fig. 3). 
4.2. ADP-actin 
As discussed by Goldschmidt-Clermont et al. [12], cells by 
the rapid turnover of actin filaments may produce a substan- 
tial amount of ADP-actin monomers. For these, assembly 
reactions in general are reduced and unfavorable. Rate limit- 
ing are the higher critical concentration and the much slower 
formation of actin nuclei of ADP-actin. Of advantage would 
be the binding of ADP-actin to a nucleation promoting pro- 
tein. Since we have previously reported that talin exhibits such 
a nucleation promoting activity using ATP-actin [5,8], it was 
of interest to investigate the influence of talin on ADP-actin 
polymerization. Indeed, we found a comparable talin induced 
increase of the polymerization rate when comparing ADP- 
actin with ATP-actin, reflected by the ?2-fold increase of 
NBD fluorescence during the early phase of polymerization. 
From this we conclude that the talin promoted nucleation of 
actin filament assembly is equally efficient for ATP-actin and 
ADP-actin. 
In summary, the interaction of two essential cellular metab- 
olites, phosphoinositolphosphates and ADP-actin, with talin 
and their effect on talin induced actin polymerization are in 
line with our interpretation of talin function hitherto: elevated 
concentrations of PIP2 and PIP resulting from receptor 
mediated cell activation may help to target and concentrate 
talin in specific areas of the plasma membrane. These hot 
spots of accumulated talin, which by immunofluorescence mi- 
croscopy were shown to closely overlap with nascent actin 
filament bundles in newly formed leading edges, may provide 
sufficient concentrated talin for the interaction with actin, 
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which is of relatively high stoichiometry in vitro when pro- 
moting actin filament nucleation. In support of the physiolo- 
gical relevance of talin nucleated actin polymerization, we 
have demonstrated that even under conditions where the nor- 
mal ATP-actin pool would be depleted, ADP-actin could 
serve as an appropriate substrate for talin to exhibit its nu- 
cleation promoting activity. 
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